We are live on !
Find out more
Rangeley Capital Portfolio holdings
AUM
$109M
Turnover
49.06%
1-Year Est. Return
97.13%
This Fund
S&P 500
This Quarter Est. Return
+34.11%
1 Year Est. Return
+97.13%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$109M
AUM Growth
+$6.53M
(+6.3%)
Cap. Flow
-$6.26M
Cap. Flow % of AUM
Cap. Flow %
-5.72%
Top 10 Holdings %
Top 10 Hldgs %
32.08%
Holding
212
New
75
Increased
28
Reduced
43
Closed
29
Avg Time Held
Equity + Options
0.4
years
Top 10 Avg Time Held
Equity + Options
0.3
years
Top 20 Avg Time Held
Equity + Options
0.4
years
Avg Time Held Equity only
0.4
years
Top 10 Avg Time Held Equity only
0.3
years
Top 20 Avg Time Held Equity only
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nomad Foods
NOMD
|
+$1.34M |
| 2 |
Mountain Lake Acquisition Corp II
MLAA
|
+$1.27M |
| 3 |
Distribution Solutions Group
DSGR
|
+$1.26M |
| 4 |
enGene Therapeutics
ENGN
|
+$1.24M |
| 5 |
Abivax
ABVX
|
+$1.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Revolution Medicines
RVMD
|
+$8.47M |
| 2 |
Leggett & Platt
LEG
|
+$2.1M |
| 3 |
Icon
ICLR
|
+$1.96M |
| 4 |
Kezar Life Sciences
KZR
|
+$1.8M |
| 5 |
Mister Car Wash
MCW
|
+$1.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.11% |
| 2 | Consumer Discretionary | 14.33% |
| 3 | Financials | 12.51% |
| 4 | Miscellaneous | 10.11% |
| 5 | Real Estate | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
CALL
Microsoft
MSFT
$3.95T
| $373K | 0.34% |
+1,000
| New | +$405K |
2026 Q2
0 quarters
|
|
77
Dauch Corp
DCH
$1.1B
| $369K | 0.34% |
+68,000
| New | +$413K |
2026 Q2
0 quarters
|
|
78
Seer Inc
SEER
$107M
| $369K | 0.34% |
222,000
+37,698
| +20% | +$68.4K |
2025 Q2
4 quarters
|
|
79
Pershing Square
PS
$18.2B
| $361K | 0.33% |
+11,000
| New | +$400K |
2026 Q2
0 quarters
|
|
80
DELISTED
STRATUS PPTYS INC
STRS
| $361K | 0.33% |
12,546
| – | – |
2026 Q1
1 quarter
|
|
81
Abeona Therapeutics
ABEO
$246M
| $359K | 0.33% |
58,100
-1,900
| -3% | -$10.4K |
2025 Q4
2 quarters
|
|
82
Braemar Hotels & Resorts
BHR
$95.5M
| $351K | 0.32% |
162,567
-59,433
| -27% | -$142K |
2025 Q4
2 quarters
|
|
83
Fifth Era Acquisition Corp I
FERA
$330M
| $349K | 0.32% |
33,458
+2,468
| +8% | +$25.6K |
2025 Q3
3 quarters
|
|
84
ProFrac Holding
ACDC
$792M
| $346K | 0.32% |
+59,578
| New | +$401K |
2026 Q2
0 quarters
|
|
85
Drugs Made In America Acquisition II Corp Unit
DMIIU
| $331K | 0.3% |
32,551
-23,061
| -41% | -$233K |
2025 Q4
2 quarters
|
|
86
Priority Technology Holdings
PRTH
$645M
| $327K | 0.3% |
49,000
-10,000
| -17% | -$57.9K |
2025 Q4
2 quarters
|
|
87
EGH Acquisition Corp
EGHA
$214M
| $324K | 0.3% |
+31,474
| New | +$324K |
2026 Q2
0 quarters
|
|
88
D. Boral Acquisition I Corp
DBCA
$435M
| $321K | 0.29% |
+32,193
| New | +$320K |
2026 Q2
0 quarters
|
|
89
Xerox Holdings Corp Warrants
XRXDW
$19.4M
| $313K | 0.29% |
+100,000
| New | +$27.2K |
2026 Q2
0 quarters
|
|
90
Renatus Tactical Acquisition Corp I
RTAC
$326M
| $311K | 0.28% |
29,659
-6,123
| -17% | -$63.6K |
2026 Q1
1 quarter
|
|
91
DELISTED
Northfield Bancorp
NFBK
| $309K | 0.28% |
+21,000
| New | +$297K |
2026 Q2
0 quarters
|
|
92
Enviri
NVRI
$538M
| $307K | 0.28% |
14,000
-14,000
| -50% | -$280K |
2025 Q4
2 quarters
|
|
93
Trilogy Metals
TMQ
$366M
| $305K | 0.28% |
87,000
| – | – |
2025 Q1
5 quarters
|
|
94
OTG Acquisition Corp I Unit
OTGAU
| $284K | 0.26% |
27,520
-23,285
| -46% | -$239K |
2025 Q3
3 quarters
|
|
95
4D Molecular Therapeutics
FDMT
$609M
| $279K | 0.25% |
20,965
-10,500
| -33% | -$102K |
2025 Q2
4 quarters
|
|
96
Lisata Therapeutics
LSTA
$11.5M
| $275K | 0.25% |
81,000
+6,000
| +8% | +$21.4K |
2026 Q1
1 quarter
|
|
97
Weave Communications
WEAV
$595M
| $274K | 0.25% |
+45,700
| New | +$249K |
2026 Q2
0 quarters
|
|
98
Exelixis
EXEL
$16.1B
| $272K | 0.25% |
5,000
| – | – |
2025 Q4
2 quarters
|
|
99
CALL
Forward Air
FWRD
$509M
| $272K | 0.25% |
20,100
| – | – |
2025 Q3
3 quarters
|
|
100
CSLM Digital Asset Acquisition Corp III Units
KOYNU
| $269K | 0.25% |
26,092
-22,852
| -47% | -$234K |
2025 Q3
3 quarters
|
|
Similar funds
S2L
Rangeley Capital's Q2 2026 Portfolio in Review
As of Q2 2026, Rangeley Capital held 212 positions worth $109M, up 6.3% from $103M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Rangeley Capital withdrew a net $6.26M in Q2 2026, closing 29 positions and reducing 43 holdings. Its most notable exit was Leggett & Platt, an estimated $2.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Rangeley Capital opened a new position in Nomad Foods worth $1.48M.
- Rangeley Capital's largest Q2 2026 buy was Nomad Foods: 135,000 shares worth $1.48M.
- Rangeley Capital added most to Distribution Solutions Group in Q2 2026, an estimated $1.26M increase.
- Rangeley Capital's biggest Q2 2026 reduction was Revolution Medicines, cutting an estimated $8.47M.
- Rangeley Capital fully exited Leggett & Platt in Q2 2026, selling an estimated $2.1M.
- Rangeley Capital's ten largest holdings make up 32% of its $109M portfolio in Q2 2026.
- Rangeley Capital opened 75 new positions and closed 29 in Q2 2026.
- Rangeley Capital's portfolio value rose 6.3% quarter-over-quarter to $109M.
Based on Rangeley Capital's 13F filing for Q2 2026, filed 14 Aug 2026.